<DOC>
	<DOC>NCT01460615</DOC>
	<brief_summary>The purpose of this randomized, placebo-controlled trial is to investigate whether postoperative pancreatitis and other immediate complications after pancreaticoduodenectomy (Whipple) operation may be reduced with cortisone treatment. Treatment is administered to high risk patients (defined by high amount of acinar cells in the cut edge of pancreas).</brief_summary>
	<brief_title>Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy (Whipple Operation)</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Cortisone</mesh_term>
	<criteria>Pancreaticoduodenectomy patients in Tampere University Hospital Patients with an ongoing cortisone treatment Cefuroxime allergy Chronic pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Postoperative pancreatitis</keyword>
	<keyword>Postoperative complications</keyword>
	<keyword>Delayed gastric emptying</keyword>
	<keyword>Leakage</keyword>
	<keyword>Fistula</keyword>
	<keyword>Acinar cell</keyword>
	<keyword>Risk patient</keyword>
	<keyword>Pancreaticoduodenectomy</keyword>
	<keyword>Whipple</keyword>
	<keyword>Cortisone</keyword>
</DOC>